Cargando…
In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in man.
Autores principales: | Philip, P. A., Bagshawe, K. D., Searle, F., Green, A. J., Begent, R. H., Newlands, E. S., Rustin, G. J., Adam, T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971655/ https://www.ncbi.nlm.nih.gov/pubmed/1989652 |
Ejemplares similares
-
Chemotherapy of advanced malignant teratomas.
por: Newlands, E. S., et al.
Publicado: (1980) -
The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
por: Crawford, S. M., et al.
Publicado: (1989) -
Bone disease in testicular and extragonadal germ cell tumours.
por: Hitchins, R. N., et al.
Publicado: (1988) -
The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivo.
por: Philip, P. A., et al.
Publicado: (1993) -
Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.
por: Hitchins, R. N., et al.
Publicado: (1989)